News
03-10-2008, 03:20 PM
A new pilot study by investigators at Memorial Sloan-Kettering Cancer Center (MSKCC) found that breast cancer patients can be treated safely with a ?dose-dense? regimen of standard chemotherapy agents and the antibody trastuzumab (Herceptin®), a drug that has previously been shown to cause cardiac toxicity.
More... (http://www.news-medical.net/?id=36029)
More... (http://www.news-medical.net/?id=36029)